Human papillomavirus (HPV) infection is the leading cause of cervical cancer. India bears 30% of the burden of cervical cancer worldwide. The lack of awareness in rural areas and the lifestyle of women in urban areas worsen the situation of cervical cancer in the country. Low-cost, eﬀective solutions are required for the prevention and treatment of HPV infections.
Academia and industries worldwide are
actively involved in finding solutions to HPV infection in terms of new
screening/diagnostic tests, vaccines and therapeutic options.
BIRAC invites proposals under its Biotechnology
Industry Partnership Program (BIPP) on HPV prevention and control. The proposals with established POC and
aspiring funding for validation and product development are encouraged under
Following are some of the indicative priority areas for submitting proposals,
This list is not exhaustive and any other priority area of importance could be considered.
ü A single or consortia of Indian company (ies) - Small, Medium or Large having in-house R&D unit(s), alone or in collaboration with a partner from another Company/Institute/Organization.
ü The main industry applicant should have DSIR* recognized in-house R&D unit; alternatively, the applicant should be incubated at an Incubation Centre/Biotech Park which has a valid SIRO/DSIR Certificate.
*(The Companies in the process of obtaining DSIR recognition may also apply along with the proof of application for DSIR. However, the final decision on such applications would be subject to their getting DSIR recognition)
Proposals are required to be submitted online only. To submit a proposal online, please log on to the BIRAC website (www.birac.nic.in).
No Hard Copy to be submitted. Proposals submitted online only would be considered.
Last date for Submission of Proposals under Regular Call: 31st July, 2014
For any queries, please contact:
Dr. Suraksha S. Diwan
Programme Officer – BIPP, BIRAC
Scientist D, Department of Biotechnology
Announcement Date: 02-07-2014
Last Submission Date: 31-07-2014 12:00 AM